Nextech Invest
Latest statistics and disclosures from Nextech Invest's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RVMD, Parabilis Medicines, RLAY, TYRA, ALMS, and represent 90.07% of Nextech Invest's stock portfolio.
- Added to shares of these 5 stocks: Parabilis Medicines (+$128M), RLAY (+$23M), GLUE (+$11M), ARVN, ENGN.
- Started 2 new stock positions in Parabilis Medicines, ENGN.
- Reduced shares in these 5 stocks: TNGX (-$152M), CGEM (-$16M), TYRA (-$16M), Engene Holdings (-$16M), SPRY.
- Sold out of its positions in CGEM, Engene Holdings, SPRY, TNGX.
- Nextech Invest was a net seller of stock by $-34M.
- Nextech Invest has $2.1B in assets under management (AUM), dropping by 47.74%.
- Central Index Key (CIK): 0001595430
Tip: Access up to 7 years of quarterly data
Positions held by Nextech Invest consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nextech Invest
Nextech Invest holds 15 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 67.8 | $1.4B | 7.6M | 187.28 |
|
|
| Parabilis Medicines | 6.1 | $128M | NEW | 4.7M | 27.37 |
|
| Relay Therapeutics (RLAY) | 6.0 | $127M | +22% | 6.8M | 18.71 |
|
| Tyra Biosciences (TYRA) | 5.4 | $114M | -12% | 3.6M | 31.94 |
|
| Alumis (ALMS) | 4.7 | $100M | 3.5M | 28.14 |
|
|
| Oric Pharmaceuticals (ORIC) | 3.7 | $78M | 7.2M | 10.83 |
|
|
| Kymera Therapeutics (KYMR) | 1.5 | $32M | 279k | 114.67 |
|
|
| Zymeworks Del (ZYME) | 1.4 | $29M | 1.1M | 26.14 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.9 | $18M | +150% | 761k | 24.20 |
|
| Cytomx Therapeutics (CTMX) | 0.8 | $17M | 4.4M | 3.75 |
|
|
| Silence Therapeutics Ads (SLN) | 0.5 | $11M | 952k | 10.98 |
|
|
| Arvinas Ord (ARVN) | 0.4 | $9.3M | +108% | 1.1M | 8.31 |
|
| Corvus Pharmaceuticals (CRVS) | 0.3 | $6.7M | 450k | 14.94 |
|
|
| Context Therapeutics (CNTX) | 0.2 | $4.1M | 7.4M | 0.55 |
|
|
| Engene Therapeutics (ENGN) | 0.2 | $4.0M | NEW | 2.3M | 1.73 |
|
Past Filings by Nextech Invest
SEC 13F filings are viewable for Nextech Invest going back to 2025
- Nextech Invest 2026 Q2 filed Aug. 14, 2026
- Nextech Invest 2026 Q1 filed May 15, 2026
- Nextech Invest 2025 Q4 filed Feb. 17, 2026
- Nextech Invest 2025 Q3 filed Nov. 14, 2025
- Nextech Invest 2025 Q2 filed Aug. 14, 2025
- Nextech Invest 2025 Q1 filed May 15, 2025